Literature DB >> 16110143

Mantle cell lymphoma presenting with paraproteinemia.

Grzegorz Rymkiewicz1, Monika Gos, Katarzyna Błachnio, Renata Woroniecka, Paweł Swoboda, Barbara Pieńkowska-Grela, Marika Kulińska, Anna Borawska, Przemysław Janik, Jan Walewski.   

Abstract

Mantle cell lymphoma (MCL) is most frequently diagnosed by the routine histological (HP) and immunohistochemical (IH) examination. Herein we present a case of 47-yr-old female with general lymphadenopathy and leukemic blood picture. She was initially diagnosed with marginal zone lymphoma (MZL). This diagnosis was based not only on the HP/IH examination but also on the presence of IgM paraproteinemia. Flow cytometry (FCM) examination was helpful in making of the final diagnosis of MCL. Fluorescence in situ hybridization and cyclin D1 mRNA detection by RT-PCR additionally confirmed the MCL diagnosis. The IgM paraproteinemia is rare in MCL, although is a common feature of lymphoplasmacytoid lymphomas (LPL) and is considered a major characteristic of Waldenström's macroglobulinemia (WM).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110143     DOI: 10.1385/MO:22:3:319

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

Review 2.  Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.

Authors:  C D Jennings; K A Foon
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

Review 3.  Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.

Authors:  Brunangelo Falini; David Y Mason
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage.

Authors:  E Vandenberghe; C De Wolf-Peeters; J van den Oord; I Wlodarska; J Delabie; M Stul; J Thomas; J L Michaux; C Mecucci; J J Cassiman
Journal:  J Pathol       Date:  1991-01       Impact factor: 7.996

5.  A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.

Authors:  Marc-Antoine Belaud-Rotureau; Marie Parrens; Pierre Dubus; Jean-Christophe Garroste; Antoine de Mascarel; Jean-Philippe Merlio
Journal:  Mod Pathol       Date:  2002-05       Impact factor: 7.842

6.  Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings.

Authors:  D D Weisenburger; W G Sanger; J O Armitage; D T Purtilo
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

7.  Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  N S Aguilera; K E Bijwaard; B Duncan; A E Krafft; W S Chu; S L Abbondanzo; J H Lichy; J K Taubenberger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.

Authors:  Pei Lin; Carlos Bueso-Ramos; Carla S Wilson; Adnan Mansoor; L Jeffrey Medeiros
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

9.  CyclinD1/CyclinD3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma.

Authors:  Carol D Jones; Katherine H Darnell; Roger A Warnke; James L Zehnder
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

10.  Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.

Authors:  W I Yang; L R Zukerberg; T Motokura; A Arnold; N L Harris
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more
  3 in total

1.  Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice.

Authors:  Pieter Van Vlierberghe; Steven Goossens; Tim Pieters; Sara T'Sas; Stijn Vanhee; André Almeida; Yasmine Driege; Juliette Roels; Wouter Van Loocke; Willem Daneels; Mathijs Baens; Arnaud Marchand; Maaike Van Trimpont; Filip Matthijssens; Julie Morscio; Kelly Lemeire; Béatrice Lintermans; Lindy Reunes; Patrick Chaltin; Fritz Offner; Jo Van Dorpe; Tino Hochepied; Geert Berx; Rudi Beyaert; Jens Staal
Journal:  J Exp Med       Date:  2021-08-18       Impact factor: 14.307

2.  Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

Authors:  Grzegorz Rymkiewicz; Konrad Ptaszyński; Jan Walewski; Katarzyna Błachnio; Pawel Swoboda; Monika Gos; Ewa Paszkiewicz-Kozik; Renata Woroniecka; Barbara Pieńkowska-Grela; Małgorzata Czarnocka; Przemysław Janik
Journal:  Med Oncol       Date:  2006       Impact factor: 3.738

3.  Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.

Authors:  Man Fai Law; Hay Nun Chan; Charlotte Leung; Cheuk Kei Wong; Ho Kei Lai; Chung Yin Ha; Celia Ng; Yiu Ming Yeung; Sze Fai Yip
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.